-
Addiction treatments of the future: The role of genetics.
Kreek MJ, Haynes LF, Cohen AJ. Addiction treatments of the future: The role of genetics. Presented at the NIDA Blending Conference, "Blending Addiction Science & Treatment: The Impact of Evidence-Based Practices on Individuals, Families, and Communities," Cincinnati, OH, June 2-3, 2008.
-
Stimulant abuser groups to engage in 12-step: An overview for the STAGE-12 executive committee.
Donovan DM. Stimulant abuser groups to engage in 12-step: An overview for the STAGE-12 executive committee. Presented at the STAGE-12 Protocol Training Meeting, Bethesda, MD, December 3, 2007.
-
Implementing EBPs in a community treatment program: Beyond instruction.
Zweben JE. Implementing EBPs in a community treatment program: Beyond instruction. Presented at the American Psychological Association (APA) Annual Convention, San Francisco, CA, August 17-20, 2007.
-
The CTN Research Utilization Committee: Putting dissemination research into practice.
Selzer JA. The CTN Research Utilization Committee: Putting dissemination research into practice. Presented at the Addiction Health Services Research Conference, October 15-17, 2007, Athens, GA.
-
Integrating services research into CTN clinical trials: The synergy is in the details.
Perl HI. Integrating services research into CTN clinical trials: The synergy is in the details. Presented at the Addiction Health Services Research Conference, October 15-17, 2007, Athens, GA.
-
Services research & the CTN: We keep getting better!
Chandler RK. Services research & the CTN: We keep getting better! Presented at the Addiction Health Services Research Conference, October 15-17, 2007, Athens, GA.
-
Rapid testing and counseling research within the CTN.
Metsch L, Sorensen JL, Colfax GN, Szapocznik J, Tross S, Mandler R. Rapid testing and counseling research within the CTN. Presented at the American Psychological Association (APA) Annual Convention, San Francisco, CA, August 17-20, 2007.
-
The value of ongoing evaluation in adopting buprenorphine-naloxone short-term taper.
Brigham GS. The value of ongoing evaluation in adopting buprenorphine-naloxone short-term taper. Presented at the American Psychological Association (APA) Annual Convention, San Francisco, CA, August 17-20, 2007.
-
Adoption of motivational interviewing/motivational enhancement therapy.
Guydish J, Manser ST, Jessup MA, Tajima B. Adoption of motivational interviewing/motivational enhancement therapy. Presented at the American Psychological Association (APA) Annual Convention, San Francisco, CA, August 17-20, 2007.
-
In the diffusion of innovations everyone changes: Linking practice with scientific research.
Sorensen JL. In the diffusion of innovations everyone changes: Linking practice with scientific research. Presented at the American Psychological Association (APA) Annual Convention, San Francisco, CA, August 17-20, 2007.